Cerulomycin a: A potent novel immunosuppressive agent

Transplantation

Volumn 97, Issue 9, 2014, Pages e57-e59

  Singla, Arvind K ^a   Gurram, Rama Krishna ^a   Chauhan, Arun ^a   Khatri, Neeraj ^a   Vohra, Rakesh M ^a   Jolly, Ravinder S ^a   Agrewala, Javed N ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOMYCIN A; IMMUNOSUPPRESSIVE AGENT; UNCLASSIFIED DRUG; 2,2' BIPYRIDINE; DRUG DERIVATIVE; TACROLIMUS;

ACTINOALLOTEICHUS SPITIENSIS; ACTINOBACTERIA; ALLOIMMUNITY; ALLOTRANSPLANTATION; CELLULAR IMMUNITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; LETTER; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; CHEMISTRY; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; MOUSE;

2,2'-DIPYRIDYL; ACTINOBACTERIA; ANIMALS; CELL PROLIFERATION; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; TACROLIMUS;

EID: 84903753360     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000119     Document Type: Letter

References (13)

1. Kuchroo VK, Ohashi PS, Sartor RB, et al. Dysregulation of immune homeostasis in autoimmune diseases. Nat Med 2012; 18: 42.
2. Larche M, Akdis CA, Valenta R. Immuno-logical mechanisms of allergen-specific im-munotherapy. Nat Rev Immunol 2006; 6: 761.
3. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715.
4. Utecht KN, Hiles JJ, Kolesar J. Effects of genetic polymorphisms on the pharmaco-kinetics of calcineurin inhibitors. Am J Health Syst Pharm 2006; 63: 2340.
5. Niioka T, Kagaya H, Miura M, et al. Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bio-availability in renal transplant recipients. Eur J Clin Pharmacol 2013; 69: 1659.
6. Thaci D, Salgo R. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies. Clin Dermatol 2010; 28: 52.
7. Naesens M, Kuypers DR, Sarwal M. Calci-neurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481.
8. Danesi R, Del Tacca M. Hematologic tox-icity of immunosuppressive treatment. Transplant Proc 2004; 36: 703.
9. Leyral C, Beylot-Barry M, Vergier B, et al. [Cyclosporine-induced follicular eruption]. Ann Dermatol Venereol 2008; 135: 58.
10. Wu MS. From bedside to bench drug-induced tubulointerstitial disease cyclospor-ine nephropathy study from models of cultured renal epithelial cells. Chang Gung Med J 2007; 30: 7.
11. Zelenika D, Adams E, Humm S, et al. The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol Rev 2001; 182: 164.
12. Issa F, Schiopu A, Wood KJ. Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol 2010; 6: 155.
13. Abbas AK, Lohr J, Knoechel B, et al. T cell tolerance and autoimmunity. Autoimmun Rev 2004; 3: 471.